Loading
PDBj
メニューPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

6F4E

Crystal structure of the zinc-free catalytic domain of botulinum neurotoxin X

6F4E の概要
エントリーDOI10.2210/pdb6f4e/pdb
関連するPDBエントリー6F47
分子名称Catalytic domain of botulinum neurotoxin X, DI(HYDROXYETHYL)ETHER (3 entities in total)
機能のキーワードbotulinum neurotoxin, botulinum toxin, zinc endopeptidase, toxin
由来する生物種Clostridium botulinum
タンパク質・核酸の鎖数1
化学式量合計52219.81
構造登録者
Masuyer, G.,Henriksson, L.,Kosenina, S.,Zhang, S.,Barkho, S.,Shen, Y.,Dong, M.,Stenmark, P. (登録日: 2017-11-29, 公開日: 2018-03-14, 最終更新日: 2024-01-17)
主引用文献Masuyer, G.,Zhang, S.,Barkho, S.,Shen, Y.,Henriksson, L.,Kosenina, S.,Dong, M.,Stenmark, P.
Structural characterisation of the catalytic domain of botulinum neurotoxin X - high activity and unique substrate specificity.
Sci Rep, 8:4518-4518, 2018
Cited by
PubMed Abstract: Botulinum neurotoxins (BoNTs) are among the most potent toxins known and are also used to treat an increasing number of medical disorders. There are seven well-established serotypes (BoNT/A-G), which all act as zinc-dependent endopeptidases targeting specific members of the SNARE proteins required for synaptic vesicle exocytosis in neurons. A new toxin serotype, BoNT/X, was recently identified. It cleaves not only the canonical targets, vesicle associated membrane proteins (VAMP) 1/2/3 at a unique site, but also has the unique ability to cleave VAMP4/5 and Ykt6. Here we report the 1.35 Å X-ray crystal structure of the light chain of BoNT/X (LC/X). LC/X shares the core fold common to all other BoNTs, demonstrating that LC/X is a bona fide member of BoNT-LCs. We found that access to the catalytic pocket of LC/X is more restricted, and the regions lining the catalytic pocket are not conserved compared to other BoNTs. Kinetic studies revealed that LC/X cleaves VAMP1 with a ten times higher efficiency than BoNT/B and the tetanus neurotoxin. The structural information provides a molecular basis to understand the convergence/divergence between BoNT/X and other BoNTs, to develop effective LC inhibitors, and to engineer new scientific tools and therapeutic toxins targeting distinct SNARE proteins in cells.
PubMed: 29540745
DOI: 10.1038/s41598-018-22842-4
主引用文献が同じPDBエントリー
実験手法
X-RAY DIFFRACTION (2.4 Å)
構造検証レポート
Validation report summary of 6f4e
検証レポート(詳細版)ダウンロードをダウンロード

247536

件を2026-01-14に公開中

PDB statisticsPDBj update infoContact PDBjnumon